FDA Data Exclusivity Guidance: Emerging Patent …

Apr 10, 2014 · FDA Data Exclusivity Guidance: Emerging Patent Challenges and Opportunities Navigating Complexities of Exclusivity, New Developments, and the Implications for ANDAs and Hatch-Waxman Litigation

  Data, Guidance, Emerging, Patent, Hatch, Exclusivity, Fda data exclusivity guidance, Emerging patent